Petrov, V.I., Nedogoda, S.V., Epshtein, O.I. et al. Bull Exp Biol Med (2009) 148: 332. doi:10.1007/s10517-009-0686-9
Kardos monotherapy allows attaining the target levels of systolic and diastolic blood pressure in patients with high-risk and very-high-risk hypertension. We demonstrated excellent tolerability of the preparation in combination with reliable blood pressure decrease over 24 h, during day and night hours.
kardos arterial hypertension 24-h monitoring ultralow doses of antibodies